Mastodawn

Praha - Česká státní správa může během příštích pěti let ztratit až 30.000 kvalifikovaných zaměstnanců, tedy asi 40 procent své současné pracovní síly. Zaměstnanci mladší 30 let nyní tvoří pouze sedm procent úředníků, tedy zhruba polovinu jejich podílu v soukromém sektoru. Vyplývá to ze studie poradenské společnosti Kearney.

Tón: : mírně pozitivní
#česko #gdelt #čr #prác...

https://www.ceskenoviny.cz/zpravy/studie-ceska-statni-sprava-muze-behem-peti-let-ztratit-40-procent-pracovni-sily/2765036

Studie: Česká státní správa může během pěti let ztratit 40 procent pracovní síly | ČeskéNoviny.cz

Privatarchiv Köster Olsberg Dec 26

Gierskopp – Kinderschützenfest 1964

https://privatarchiv.rzgierskopp.de/1964/06/kinderschuetzenfest-auf-der-gierskopp-1964/
---
#AlbaumFranz #Antfeld #BeckEdmund #BofingerHermann #CordesKarl #DeutschesKaiserreich #Dokumente #Fest #GastronomieAufDerGierskopp #GaststtteHckelheim #GebudeAufDerGierskopp #Gierskopp #GieseErich #Grndung #HillebrandRobert #HhleWerner #HckelheimFranz #HckelheimFrieda #Kienegge #KriegUndNachkriegszeit #Kultur #Lingelscheid #MuchaGerd #NiggemannRichard #Olsberg #Prac

Eddy Jansson Apr 22, 2024

The inital DDR5 spec started at DDR5-3200, with a peak bandwidth around 25GiB/s, going up to DDR5-6400 which doubles that to ~50GiB/s.

Now DDR5-8800 has been specced out, at around 70GiB/s.

I see two 'islands' coming; 3x and 4x the original 3200MT, which would be DDR5-9600 and DDR5-12800, the latter hitting a bandwidth of ~100GiB/s.

With latencies not improving, large CPU caches will remain a necessity at the high-end.

https://www.anandtech.com/show/21363/jedec-extends-ddr5-specification-to-8800-mts-adds-anti-rowhammer-features

#JEDEC #DDR5 #Memory #RowHammer #PRAC #PRHT

JEDEC Extends DDR5 Memory Specification to 8800 MT/s, Adds Anti-Rowhammer Features

When JEDEC released its DDR5 specification (JESD79) back in 2020, the standard setting organization defined precise specs for modules with speed bins of up...

AnandTech

EU Health - #HealthUnion Jul 11, 2023

RT EU Medicines Agency
EMA’s #safety committee, the #PRAC, is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with GLP-1 receptor agonists used for weight loss and for treating type 2 #diabetes.
Read more in the news announcement: https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists https://t.co/Rf3Ly9FGbM

🐦🔗: https://n.respublicae.eu/EMA_News/status/1678794781256761346

EMA statement on ongoing review of GLP-1 receptor agonists | European Medicines Agency

EU Medicines Agency Jul 7, 2023

EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.
More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-3-6-july-2023
#SafetyOfMedicines https://t.co/D0EHywwIMF

🐦🔗: https://n.respublicae.eu/EMA_News/status/1677261762968662016

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023 European Medicines Agency

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023

European Medicines Agency

EU Medicines Agency Jun 9, 2023

At its June meeting, EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.

More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-june-2023

#SafetyOfMedicines

🐦🔗: https://n.respublicae.eu/EMA_News/status/1667127819984306176

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023 European Medicines Agency

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023

European Medicines Agency

Show thread

EU Medicines Agency Jun 6, 2023

If an unusual pattern emerged, the #PRAC performed an in-depth analysis of the reports to quickly identify potential safety issues with #Covid19vaccines.

The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging #safety issues quickly.

#EMAPresser

🐦🔗: https://n.respublicae.eu/EMA_News/status/1666080058241581057

EU Medicines Agency (@EMA_News)

If an unusual pattern emerged, the #PRAC performed an in-depth analysis of the reports to quickly identify potential safety issues with #Covid19vaccines. The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging #safety issues quickly. #EMAPresser

Nitter

Show thread

EU Medicines Agency Jun 6, 2023

We placed extra obligations on the #Covid19vaccine makers.

They had to provide us with detailed monthly reports on the #safety of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the #PRAC, until December 2022.

#EMAPresser

🐦🔗: https://n.respublicae.eu/EMA_News/status/1666079498784366597

EU Medicines Agency (@EMA_News)

We placed extra obligations on the #Covid19vaccine makers. They had to provide us with detailed monthly reports on the #safety of their vaccine ➡️ 5⃣6⃣monthly reports were assessed by our safety committee, the #PRAC, until December 2022. #EMAPresser

Nitter

EU Medicines Agency Mar 17, 2023

EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.

More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-march-2023

#SafetyOfMedicines

🐦🔗: https://n.respublicae.eu/EMA_News/status/1636691621998673920

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023 European Medicines Agency

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023

European Medicines Agency

EU Medicines Agency Feb 10, 2023

At its February meeting, EMA's safety committee, the #PRAC, started a safety review of medicines containing pseudoephedrine.

#PublicHealth #SafetyOfMedicines

➡️ https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-6-9-february-2023

🐦🔗: https://n.respublicae.eu/EMA_News/status/1624037832950939650

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6 - 9 February 2023 European Medicines Agency

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6 - 9 February 2023

European Medicines Agency